Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13617
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jindal, Anil B. | - |
dc.date.accessioned | 2024-01-03T04:49:04Z | - |
dc.date.available | 2024-01-03T04:49:04Z | - |
dc.date.issued | 2023-12 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0169409X23004787?via%3Dihub | - |
dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13617 | - |
dc.description.abstract | High dosing frequency poses a considerable challenge in treating chronic conditions. This often results in missed doses, ultimately leading to therapy failure. Formulations capable of maintaining a prolonged plasma drug concentration, preferably spanning weeks to months or even years, are highly desirable. Long-acting therapeutics have emerged as a significant improvement in the treatment of chronic diseases. Recently, long-acting formulations have demonstrated substantial potential in preventing and treating chronic infections such as HIV/AIDS, tuberculosis, and malaria. Long-acting antiretroviral formulations have received approval from the USFDA for both preexposure prophylaxis and the treatment of HIV/AIDS. Moreover, ongoing extensive research is exploring the potential of long-acting formulations for treating tuberculosis and malaria, promising the eventual availability of LATs for these diseases in the market. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.subject | Pharmacy | en_US |
dc.subject | HIV/AIDS | en_US |
dc.subject | Tuberculosis | en_US |
dc.subject | Malaria parasite | en_US |
dc.title | Long-acting therapeutics: development strategies and clinical significance | en_US |
dc.type | Article | en_US |
Appears in Collections: | Department of Pharmacy |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.